Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 09:35:19 UTC |
---|
Update Date | 2021-09-26 23:04:14 UTC |
---|
HMDB ID | HMDB0251940 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Esaprazole |
---|
Description | Esaprazole, also known as hexaprazol, belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. Esaprazole is a very strong basic compound (based on its pKa). This compound has been identified in human blood as reported by (PMID: 31557052 ). Esaprazole is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Esaprazole is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | InChI=1S/C12H23N3O/c16-12(10-15-8-6-13-7-9-15)14-11-4-2-1-3-5-11/h11,13H,1-10H2,(H,14,16) |
---|
Synonyms | Value | Source |
---|
Esaprazole monohydrochloride | MeSH | N-((N-Cyclohexylcarbamoyl)methyl)piperazine | MeSH | Hexaprazol | MeSH |
|
---|
Chemical Formula | C12H23N3O |
---|
Average Molecular Weight | 225.336 |
---|
Monoisotopic Molecular Weight | 225.184112373 |
---|
IUPAC Name | N-cyclohexyl-2-(piperazin-1-yl)ethanimidic acid |
---|
Traditional Name | N-cyclohexyl-2-(piperazin-1-yl)ethanimidic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | OC(CN1CCNCC1)=NC1CCCCC1 |
---|
InChI Identifier | InChI=1S/C12H23N3O/c16-12(10-15-8-6-13-7-9-15)14-11-4-2-1-3-5-11/h11,13H,1-10H2,(H,14,16) |
---|
InChI Key | RTFADALJKSFJDZ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Alpha amino acid amides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-amino acid amide
- N-piperazineacetamide
- N-alkylpiperazine
- 1,4-diazinane
- Piperazine
- Carboxamide group
- Secondary carboxylic acid amide
- Tertiary amine
- Tertiary aliphatic amine
- Secondary aliphatic amine
- Secondary amine
- Azacycle
- Organoheterocyclic compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Amine
- Carbonyl group
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Esaprazole,2TMS,isomer #1 | C[Si](C)(C)OC(CN1CCN([Si](C)(C)C)CC1)=NC1CCCCC1 | 2099.5 | Semi standard non polar | 33892256 | Esaprazole,2TMS,isomer #1 | C[Si](C)(C)OC(CN1CCN([Si](C)(C)C)CC1)=NC1CCCCC1 | 2079.1 | Standard non polar | 33892256 | Esaprazole,2TMS,isomer #1 | C[Si](C)(C)OC(CN1CCN([Si](C)(C)C)CC1)=NC1CCCCC1 | 2972.9 | Standard polar | 33892256 | Esaprazole,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(CN1CCN([Si](C)(C)C(C)(C)C)CC1)=NC1CCCCC1 | 2506.5 | Semi standard non polar | 33892256 | Esaprazole,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(CN1CCN([Si](C)(C)C(C)(C)C)CC1)=NC1CCCCC1 | 2429.8 | Standard non polar | 33892256 | Esaprazole,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(CN1CCN([Si](C)(C)C(C)(C)C)CC1)=NC1CCCCC1 | 3090.9 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Esaprazole GC-MS (Non-derivatized) - 70eV, Positive | splash10-003v-9400000000-8cd38aedae4d2d9e4fb9 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Esaprazole GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Esaprazole GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Esaprazole GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Esaprazole GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Esaprazole GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Esaprazole 10V, Positive-QTOF | splash10-0002-9010000000-174c3da6e847abc0da68 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Esaprazole 20V, Positive-QTOF | splash10-0002-9000000000-b2ee3d37f7190c1d4a25 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Esaprazole 40V, Positive-QTOF | splash10-05fu-9000000000-71d6b49762be7bf75ab0 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Esaprazole 10V, Negative-QTOF | splash10-00di-1190000000-74ad9f4016e046b80161 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Esaprazole 20V, Negative-QTOF | splash10-00dj-9560000000-4999f42fcbf25a86810d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Esaprazole 40V, Negative-QTOF | splash10-0007-9000000000-bad6aa23b36961f176d3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Esaprazole 10V, Positive-QTOF | splash10-004i-0090000000-f1d93e7cbe1a25addf7b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Esaprazole 20V, Positive-QTOF | splash10-004i-1190000000-65c890d35290e42a5197 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Esaprazole 40V, Positive-QTOF | splash10-0002-9200000000-aa3fe311ca6ee98165be | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Esaprazole 10V, Negative-QTOF | splash10-00di-0090000000-cfa62e996d95535b0a69 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Esaprazole 20V, Negative-QTOF | splash10-00dj-7290000000-70367c500b3e3517f246 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Esaprazole 40V, Negative-QTOF | splash10-0007-9300000000-78df514b3f37c0777152 | 2021-10-12 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum |
|
---|